Publications

2023

• Bertschi, N. L., Steck, O., Luther, F., Bazzini, C., von Meyenn, L., Schärli, S., Vallone, A., Felser, A., Keller, I., Friedli, O., Freigang, S., Begré, N., Radonjic-Hoesli, S., Lamos, C., Gabutti, M. P., Benzaquen, M., Laimer, M., Simon, D., Nuoffer, J. M., & Schlapbach, C. (2023). PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis. Nature communications, 2023. PMID: 37120582

2022

• Roediger B, Schlapbach C. T cells in the skin: Lymphoma and inflammatory skin disease. J Allergy Clin Immunol. 2022. PMID: 35247433

2021

• Zwicky, P., Ingelfinger, F., Silva de Melo, B. M., Ruchti, F., Schärli, S., Puertas, N., Lutz, M., Phan, T. S., Kündig, T. M., Levesque, M. P., Maul, J. T., Schlapbach, C., LeibundGut-Landmann, S., Mundt, S., & Becher, B. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation. Sci immunology. 2021. PMID: 34678045
• Bertschi NL, Bazzini C, Schlapbach C. The Concept of Pathogenic TH2 Cells: Collegium Internationale Allergologicum Update 2021. Int Arch Allergy Immunol. 2021. PMID: 33845475
• Steck, O., Bertschi, N. L., Luther, F., van den Berg, J., Winkel, D. J., Holbro, A., & Schlapbach, C. Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome. J Eur Acad Dermatol Venereol. 2021. PMID: 33068311